Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Restless Legs Syndrome
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Restless Legs Syndrome
    Gabapentin Enacarbil Improves Functioning, Quality of Life, and Mood in Patients With Primary Restless Legs Syndrome: Presented at MDS - (DGDispatch)
    Gabapentin Enacarbil Relieves Pain Associated With Restless Legs Syndrome: Presented at APS - (DGDispatch)
    High Waist Circumference, Obesity Linked to Increased Risk of RLS - (DGNews)
    Oestradiol Levels During Pregnancy Linked to Increased Risk of RLS - (DGNews)

    News archive

     Recent webcasts/CME

      Webcasts/CME archive

       Recent cases

        Cases archive
          




        my personal edition > restless legs syndrome > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Pregabalin Appears to be a Promising Alternative for the Treatment of RLS

          SEATTLE, Wash -- May 5, 2009 -- A drug widely used to treat seizures and anxiety appears to be an effective treatment for restless legs syndrome (RLS) and helps people with the disorder get a better night's sleep, according to a study that was presented as in a late-breaking abstract at the American Academy of Neurology (AAN) 61st Annual Meeting.

          The 12-week study involved 58 people with RLS. Of the group, 30 people received pregabalin and the rest received placebo. Doses started at 150 mg per day, but could be decreased or increased to a maximum dose of 600 mg/day. Sleep studies were performed at the beginning and end of the research.

          Researchers found nearly two-thirds of the people who took pregabalin had no RLS symptoms while taking the drug. For people who still had symptoms, those symptoms had improved by 66% while taking the drug, compared with the placebo group where symptoms worsened by 29%.

          Sleep also improved for those taking pregabalin. The study showed the group spent more time in slow wave sleep (stage 3 sleep) and spent less time in the lighter sleep stages (stage 1 or stage 2 sleep) compared with those taking placebo.

          "Since RLS symptoms get worse at night, it's difficult for people with RLS to get adequate sleep," said study author Diego Garcia-Borreguero, MD, Sleep Research Institute, Madrid, Spain.

          "However, our findings show pregabalin helped people get more deep sleep. The drug was well tolerated and is a promising alternative to current treatments because of its superior effects on quality of sleep."

          SOURCE: American Academy of Neurology




        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send